Low doses of simvastatin potentiate the effect of sodium alendronate in inhibiting bone resorption and restore microstructural and mechanical bone properties in glucocorticoid-induced osteoporosis

Detalhes bibliográficos
Autor(a) principal: Sequetto, Priscila L.
Data de Publicação: 2017
Outros Autores: Gonçalves, Reggiani V., Pinto, Aloísio S., Oliveira, Maria G. A., Maldonado, Izabel R. S. C., Oliveira, Tânia T., Novaes, Rômulo D.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: LOCUS Repositório Institucional da UFV
Texto Completo: http://dx.doi.org/10.1017/S1431927617012363
http://www.locus.ufv.br/handle/123456789/22685
Resumo: By using an experimental model of dexamethasone-induced osteoporosis we investigated the effects of different therapeutic schemes combining sodium alendronate (SA) and simvastatin on bone mineral and protein composition, microstructural and mechanical remodeling. Wistar rats were randomized into eight groups: G1: non-osteoporotic; G2: osteoporotic; G3, G4, and G5: osteoporotic + SA (0.2, 0.4, and 0.8 mg/kg, respectively); G6, G7, and G8: osteoporotic + SA (0.2, 0.4, and 0.8 mg/kg, respectively) + simvastatin (0.4, 0.6, and 1 mg/kg, respectively). Osteoporosis was induced by dexamethasone (7 mg/kg, i.m.) once a week for 5 weeks. All treatments were administered for 8 weeks. Dexamethasone increased serum levels of alkaline phosphatase, calcium, phosphorus, and urea, especially in non-treated animals, which showed severe osteoporosis. Dexamethasone also induced bone microstructural fragility and reduced mechanical resistance, which were associated with a marked depletion in mineral mass, collagenous and non-collagenous protein levels in cortical and cancellous bone. Although SA has attenuated osteoporosis severity, the effectiveness of drug therapy was enhanced combining alendronate and simvastatin. The restoration in serum parameters, organic and inorganic bone mass, and mechanical behavior showed a dose-dependent effect that was potentially related to the complementary mechanisms by which each drug acts to induce bone anabolism, accelerating tissue repair.
id UFV_59e02d0c0abd857af381ea3d4407b41d
oai_identifier_str oai:locus.ufv.br:123456789/22685
network_acronym_str UFV
network_name_str LOCUS Repositório Institucional da UFV
repository_id_str 2145
spelling Low doses of simvastatin potentiate the effect of sodium alendronate in inhibiting bone resorption and restore microstructural and mechanical bone properties in glucocorticoid-induced osteoporosisBoneGlucocorticoidMicroanalysisPathologyScanning electron microscopyBy using an experimental model of dexamethasone-induced osteoporosis we investigated the effects of different therapeutic schemes combining sodium alendronate (SA) and simvastatin on bone mineral and protein composition, microstructural and mechanical remodeling. Wistar rats were randomized into eight groups: G1: non-osteoporotic; G2: osteoporotic; G3, G4, and G5: osteoporotic + SA (0.2, 0.4, and 0.8 mg/kg, respectively); G6, G7, and G8: osteoporotic + SA (0.2, 0.4, and 0.8 mg/kg, respectively) + simvastatin (0.4, 0.6, and 1 mg/kg, respectively). Osteoporosis was induced by dexamethasone (7 mg/kg, i.m.) once a week for 5 weeks. All treatments were administered for 8 weeks. Dexamethasone increased serum levels of alkaline phosphatase, calcium, phosphorus, and urea, especially in non-treated animals, which showed severe osteoporosis. Dexamethasone also induced bone microstructural fragility and reduced mechanical resistance, which were associated with a marked depletion in mineral mass, collagenous and non-collagenous protein levels in cortical and cancellous bone. Although SA has attenuated osteoporosis severity, the effectiveness of drug therapy was enhanced combining alendronate and simvastatin. The restoration in serum parameters, organic and inorganic bone mass, and mechanical behavior showed a dose-dependent effect that was potentially related to the complementary mechanisms by which each drug acts to induce bone anabolism, accelerating tissue repair.Microscopy and Microanalysis2018-12-04T12:36:46Z2018-12-04T12:36:46Z2017-10info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlepdfapplication/pdf1435-8115http://dx.doi.org/10.1017/S1431927617012363http://www.locus.ufv.br/handle/123456789/22685engVolume 23, Issue 5, Pages 989- 1001, October 2017Sequetto, Priscila L.Gonçalves, Reggiani V.Pinto, Aloísio S.Oliveira, Maria G. A.Maldonado, Izabel R. S. C.Oliveira, Tânia T.Novaes, Rômulo D.info:eu-repo/semantics/openAccessreponame:LOCUS Repositório Institucional da UFVinstname:Universidade Federal de Viçosa (UFV)instacron:UFV2024-07-12T07:50:21Zoai:locus.ufv.br:123456789/22685Repositório InstitucionalPUBhttps://www.locus.ufv.br/oai/requestfabiojreis@ufv.bropendoar:21452024-07-12T07:50:21LOCUS Repositório Institucional da UFV - Universidade Federal de Viçosa (UFV)false
dc.title.none.fl_str_mv Low doses of simvastatin potentiate the effect of sodium alendronate in inhibiting bone resorption and restore microstructural and mechanical bone properties in glucocorticoid-induced osteoporosis
title Low doses of simvastatin potentiate the effect of sodium alendronate in inhibiting bone resorption and restore microstructural and mechanical bone properties in glucocorticoid-induced osteoporosis
spellingShingle Low doses of simvastatin potentiate the effect of sodium alendronate in inhibiting bone resorption and restore microstructural and mechanical bone properties in glucocorticoid-induced osteoporosis
Sequetto, Priscila L.
Bone
Glucocorticoid
Microanalysis
Pathology
Scanning electron microscopy
title_short Low doses of simvastatin potentiate the effect of sodium alendronate in inhibiting bone resorption and restore microstructural and mechanical bone properties in glucocorticoid-induced osteoporosis
title_full Low doses of simvastatin potentiate the effect of sodium alendronate in inhibiting bone resorption and restore microstructural and mechanical bone properties in glucocorticoid-induced osteoporosis
title_fullStr Low doses of simvastatin potentiate the effect of sodium alendronate in inhibiting bone resorption and restore microstructural and mechanical bone properties in glucocorticoid-induced osteoporosis
title_full_unstemmed Low doses of simvastatin potentiate the effect of sodium alendronate in inhibiting bone resorption and restore microstructural and mechanical bone properties in glucocorticoid-induced osteoporosis
title_sort Low doses of simvastatin potentiate the effect of sodium alendronate in inhibiting bone resorption and restore microstructural and mechanical bone properties in glucocorticoid-induced osteoporosis
author Sequetto, Priscila L.
author_facet Sequetto, Priscila L.
Gonçalves, Reggiani V.
Pinto, Aloísio S.
Oliveira, Maria G. A.
Maldonado, Izabel R. S. C.
Oliveira, Tânia T.
Novaes, Rômulo D.
author_role author
author2 Gonçalves, Reggiani V.
Pinto, Aloísio S.
Oliveira, Maria G. A.
Maldonado, Izabel R. S. C.
Oliveira, Tânia T.
Novaes, Rômulo D.
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Sequetto, Priscila L.
Gonçalves, Reggiani V.
Pinto, Aloísio S.
Oliveira, Maria G. A.
Maldonado, Izabel R. S. C.
Oliveira, Tânia T.
Novaes, Rômulo D.
dc.subject.por.fl_str_mv Bone
Glucocorticoid
Microanalysis
Pathology
Scanning electron microscopy
topic Bone
Glucocorticoid
Microanalysis
Pathology
Scanning electron microscopy
description By using an experimental model of dexamethasone-induced osteoporosis we investigated the effects of different therapeutic schemes combining sodium alendronate (SA) and simvastatin on bone mineral and protein composition, microstructural and mechanical remodeling. Wistar rats were randomized into eight groups: G1: non-osteoporotic; G2: osteoporotic; G3, G4, and G5: osteoporotic + SA (0.2, 0.4, and 0.8 mg/kg, respectively); G6, G7, and G8: osteoporotic + SA (0.2, 0.4, and 0.8 mg/kg, respectively) + simvastatin (0.4, 0.6, and 1 mg/kg, respectively). Osteoporosis was induced by dexamethasone (7 mg/kg, i.m.) once a week for 5 weeks. All treatments were administered for 8 weeks. Dexamethasone increased serum levels of alkaline phosphatase, calcium, phosphorus, and urea, especially in non-treated animals, which showed severe osteoporosis. Dexamethasone also induced bone microstructural fragility and reduced mechanical resistance, which were associated with a marked depletion in mineral mass, collagenous and non-collagenous protein levels in cortical and cancellous bone. Although SA has attenuated osteoporosis severity, the effectiveness of drug therapy was enhanced combining alendronate and simvastatin. The restoration in serum parameters, organic and inorganic bone mass, and mechanical behavior showed a dose-dependent effect that was potentially related to the complementary mechanisms by which each drug acts to induce bone anabolism, accelerating tissue repair.
publishDate 2017
dc.date.none.fl_str_mv 2017-10
2018-12-04T12:36:46Z
2018-12-04T12:36:46Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv 1435-8115
http://dx.doi.org/10.1017/S1431927617012363
http://www.locus.ufv.br/handle/123456789/22685
identifier_str_mv 1435-8115
url http://dx.doi.org/10.1017/S1431927617012363
http://www.locus.ufv.br/handle/123456789/22685
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Volume 23, Issue 5, Pages 989- 1001, October 2017
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv pdf
application/pdf
dc.publisher.none.fl_str_mv Microscopy and Microanalysis
publisher.none.fl_str_mv Microscopy and Microanalysis
dc.source.none.fl_str_mv reponame:LOCUS Repositório Institucional da UFV
instname:Universidade Federal de Viçosa (UFV)
instacron:UFV
instname_str Universidade Federal de Viçosa (UFV)
instacron_str UFV
institution UFV
reponame_str LOCUS Repositório Institucional da UFV
collection LOCUS Repositório Institucional da UFV
repository.name.fl_str_mv LOCUS Repositório Institucional da UFV - Universidade Federal de Viçosa (UFV)
repository.mail.fl_str_mv fabiojreis@ufv.br
_version_ 1822610664660664320